HRD1 reduction promotes cholesterol-induced vascular smooth muscle cell phenotypic change via endoplasmic reticulum stress.
Linli WangZhitao RenLin WuXimei ZhangMin WangHaiming NiuXuemin HeHeting WangYanming ChenGuojun ShiXiaoxian QianPublished in: Molecular and cellular biochemistry (2023)
Phenotypic change of vascular smooth muscle cells (VSMCs) is the main contributor of vascular pathological remodeling in atherosclerosis. The endoplasmic reticulum (ER) is critical for maintaining VSMC function through elimination of misfolded proteins that impair VSMC cellular function. ER-associated degradation (ERAD) is an ER-mediated process that controls protein quality by clearing misfolded proteins. One of the critical regulators of ERAD is HRD1, which also plays a vital role in lipid metabolism. However, the function of HRD1 in VSMCs of atherosclerotic vessels remains poorly understood. The level of HRD1 expression was analyzed in aortic tissues of mice fed with a high-fat diet (HFD). The H&E and EVG (VERHOEFF'S VAN GIESON) staining were used to demonstrate pathological vascular changes. IF (immunofluorescence) and WB (western blot) were used to explore the signaling pathways in vivo and in vitro. The wound closure and transwell assays were also used to test the migration rate of VSMCs. CRISPR gene editing and transcriptomic analysis were applied in vitro to explore the cellular mechanism. Our data showed significant reduction of HRD1 in aortic tissues of mice under HFD feeding. VSMC phenotypic change and HRD1 downregulation were detected by cholesterol supplement. Transcriptomic and further analysis of HRD1-KO VSMCs showed that HRD1 deficiency induced the expression of genes related to ER stress response, proliferation and migration, but reduced the contractile-related genes in VSMCs. HRD1 deficiency also exacerbated the proliferation, migration and ROS production of VSMCs induced by cholesterol, which promoted the VSMC dedifferentiation. Our results showed that HRD1 played an essential role in the contractile homeostasis of VSMCs by negatively regulating ER stress response. Thus, HRD1 in VSMCs could serve as a potential therapeutic target in metabolic disorder-induced vascular remodeling.
Keyphrases
- vascular smooth muscle cells
- endoplasmic reticulum
- high fat diet
- angiotensin ii
- smooth muscle
- endoplasmic reticulum stress
- signaling pathway
- estrogen receptor
- poor prognosis
- high glucose
- diabetic rats
- gene expression
- cardiovascular disease
- skeletal muscle
- insulin resistance
- adipose tissue
- breast cancer cells
- left ventricular
- induced apoptosis
- drug induced
- cell death
- aortic valve
- heart failure
- metabolic syndrome
- risk assessment
- binding protein
- climate change
- coronary artery
- transcription factor
- bone marrow
- cell therapy
- endothelial cells
- machine learning
- big data
- high throughput
- pulmonary arterial hypertension
- smoking cessation
- human health